Ensure your successful entrance into the Ovarian cancer market.
By Dominique Fontanilla, Senior Analyst
29 October 2015
I joined Datamonitor Healthcare’s disease team in 2014 having previously worked as a biochemistry postdoctoral fellow ...
Read full bio
Entering an established market as a new player can be daunting. Often it’s difficult to know exactly where you should be targeting your trial, and also who you should be targeting your treatment at.
Our newest infographic brings you data from Datamonitor Healthcare and our sisters product Trialtrove and Sitetrove. By combining these products, you can be assured of a comprehensive view of this market, enabling you to make a confident entry into the ovarian cancer market.
What will you learn from this infographic?
- The number of investigators and prevalent cases of ovarian cancer in the 7 major markets
- A list of competitors including the phase their trials are currently in
- Potential patient share segmented by drug class
Download the infographic by filling out the form now >>
Posted in Oncology.